Clinical Trial Update: A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety study of fezolinetant in Japanese women going through menopause to treat hot flashes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Fezolinetant (fezolinetant)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Hot Flashes | Phase 3 | Status: COMPLETED